Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis.

Identifieur interne : 000A84 ( Main/Exploration ); précédent : 000A83; suivant : 000A85

Mechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis.

Auteurs : Ifeoluwa O. Awogbindin [Nigeria] ; David O. Olaleye [Nigeria] ; Ebenezer O. Farombi [Nigeria]

Source :

RBID : pubmed:28116826

Descripteurs français

English descriptors

Abstract

Implicated in influenza-associated pathology are innate defence overzealousness and unabated secretion of oxidative tissue-sensitive antimicrobial agents. At different time points, mice were pre-treated with kolaviron (400 mg/kg), a natural antioxidant and anti-inflammatory agent, and subsequently challenged with 2 LD50 influenza A/H3N2/Perth/16/09 virus. After euthanasia at day 6, blood, lungs, liver and spleen were collected and processed for biochemical, immunohistochemical and flow cytometric assessment of redo-inflammatory imbalance, cytokine storm indices and T helper 1 host response. Previously kolaviron was reported to delay mortality onset, improve morbidity and attenuate myeloperoxidase activity and nitric oxide production with minimal impact on viral clearance. This study additionally confirmed nitric oxide, but not hydrogen peroxide, as the major culprit implicated in influenza virus-induced oxido-pathology. Systemic effect of the sustained inflammation and nitrosative stress was more prominent in the spleen and lung than in the liver of mice infected with A/H3N2/Perth/16/09. Influential to immunopathology was heightened pulmonary expression of IL-1β, RANTES, IL-10, MCP-1, NF-κB, iNOS and COX-2. However, kolaviron combated the influenza-established nitrative stress, reversed the elicited cytokine storm and restored the oxidized environment to a reductive milieu. Our data also suggest that kolaviron administration early in infection may foster CD4+ response. These data indicate that kolaviron may confer disease-dwindling properties during acute influenza infection via a system-wide protective approach involving multiple targets especially at the early stage of the infection.

DOI: 10.1111/apm.12640
PubMed: 28116826


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis.</title>
<author>
<name sortKey="Awogbindin, Ifeoluwa O" sort="Awogbindin, Ifeoluwa O" uniqKey="Awogbindin I" first="Ifeoluwa O" last="Awogbindin">Ifeoluwa O. Awogbindin</name>
<affiliation wicri:level="4">
<nlm:affiliation>Departments of Biochemistry University of Ibadan, Ibadan, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Departments of Biochemistry University of Ibadan, Ibadan</wicri:regionArea>
<orgName type="university">Université d'Ibadan</orgName>
<placeName>
<settlement type="city">Ibadan</settlement>
<region type="region">État d'Oyo</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Olaleye, David O" sort="Olaleye, David O" uniqKey="Olaleye D" first="David O" last="Olaleye">David O. Olaleye</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Virology, University of Ibadan, Ibadan, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Department of Virology, University of Ibadan, Ibadan</wicri:regionArea>
<orgName type="university">Université d'Ibadan</orgName>
<placeName>
<settlement type="city">Ibadan</settlement>
<region type="region">État d'Oyo</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Farombi, Ebenezer O" sort="Farombi, Ebenezer O" uniqKey="Farombi E" first="Ebenezer O" last="Farombi">Ebenezer O. Farombi</name>
<affiliation wicri:level="4">
<nlm:affiliation>Departments of Biochemistry University of Ibadan, Ibadan, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Departments of Biochemistry University of Ibadan, Ibadan</wicri:regionArea>
<orgName type="university">Université d'Ibadan</orgName>
<placeName>
<settlement type="city">Ibadan</settlement>
<region type="region">État d'Oyo</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28116826</idno>
<idno type="pmid">28116826</idno>
<idno type="doi">10.1111/apm.12640</idno>
<idno type="wicri:Area/PubMed/Corpus">000326</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000326</idno>
<idno type="wicri:Area/PubMed/Curation">000325</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000325</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000318</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000318</idno>
<idno type="wicri:Area/Ncbi/Merge">000847</idno>
<idno type="wicri:Area/Ncbi/Curation">000847</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000847</idno>
<idno type="wicri:Area/Main/Merge">000A85</idno>
<idno type="wicri:Area/Main/Curation">000A84</idno>
<idno type="wicri:Area/Main/Exploration">000A84</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Mechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis.</title>
<author>
<name sortKey="Awogbindin, Ifeoluwa O" sort="Awogbindin, Ifeoluwa O" uniqKey="Awogbindin I" first="Ifeoluwa O" last="Awogbindin">Ifeoluwa O. Awogbindin</name>
<affiliation wicri:level="4">
<nlm:affiliation>Departments of Biochemistry University of Ibadan, Ibadan, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Departments of Biochemistry University of Ibadan, Ibadan</wicri:regionArea>
<orgName type="university">Université d'Ibadan</orgName>
<placeName>
<settlement type="city">Ibadan</settlement>
<region type="region">État d'Oyo</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Olaleye, David O" sort="Olaleye, David O" uniqKey="Olaleye D" first="David O" last="Olaleye">David O. Olaleye</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Virology, University of Ibadan, Ibadan, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Department of Virology, University of Ibadan, Ibadan</wicri:regionArea>
<orgName type="university">Université d'Ibadan</orgName>
<placeName>
<settlement type="city">Ibadan</settlement>
<region type="region">État d'Oyo</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Farombi, Ebenezer O" sort="Farombi, Ebenezer O" uniqKey="Farombi E" first="Ebenezer O" last="Farombi">Ebenezer O. Farombi</name>
<affiliation wicri:level="4">
<nlm:affiliation>Departments of Biochemistry University of Ibadan, Ibadan, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Departments of Biochemistry University of Ibadan, Ibadan</wicri:regionArea>
<orgName type="university">Université d'Ibadan</orgName>
<placeName>
<settlement type="city">Ibadan</settlement>
<region type="region">État d'Oyo</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">APMIS : acta pathologica, microbiologica, et immunologica Scandinavica</title>
<idno type="eISSN">1600-0463</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Anti-Inflammatory Agents (pharmacology)</term>
<term>Antioxidants (pharmacology)</term>
<term>Disease Models, Animal</term>
<term>Flavonoids (pharmacology)</term>
<term>Immunohistochemistry</term>
<term>Inflammation (pathology)</term>
<term>Lung (drug effects)</term>
<term>Lung (pathology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Orthomyxoviridae Infections (pathology)</term>
<term>Oxidative Stress (drug effects)</term>
<term>Pneumonia, Viral (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Anti-inflammatoires (pharmacologie)</term>
<term>Antioxydants (pharmacologie)</term>
<term>Flavonoïdes (pharmacologie)</term>
<term>Immunohistochimie</term>
<term>Infections à Orthomyxoviridae (anatomopathologie)</term>
<term>Inflammation (anatomopathologie)</term>
<term>Modèles animaux de maladie humaine</term>
<term>Pneumopathie virale (anatomopathologie)</term>
<term>Poumon ()</term>
<term>Poumon (anatomopathologie)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Stress oxydatif ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-Inflammatory Agents</term>
<term>Antioxidants</term>
<term>Flavonoids</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Infections à Orthomyxoviridae</term>
<term>Inflammation</term>
<term>Pneumopathie virale</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Lung</term>
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Inflammation</term>
<term>Lung</term>
<term>Orthomyxoviridae Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Anti-inflammatoires</term>
<term>Antioxydants</term>
<term>Flavonoïdes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Disease Models, Animal</term>
<term>Immunohistochemistry</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Immunohistochimie</term>
<term>Modèles animaux de maladie humaine</term>
<term>Poumon</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Stress oxydatif</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Implicated in influenza-associated pathology are innate defence overzealousness and unabated secretion of oxidative tissue-sensitive antimicrobial agents. At different time points, mice were pre-treated with kolaviron (400 mg/kg), a natural antioxidant and anti-inflammatory agent, and subsequently challenged with 2 LD
<sub>50</sub>
influenza A/H3N2/Perth/16/09 virus. After euthanasia at day 6, blood, lungs, liver and spleen were collected and processed for biochemical, immunohistochemical and flow cytometric assessment of redo-inflammatory imbalance, cytokine storm indices and T helper 1 host response. Previously kolaviron was reported to delay mortality onset, improve morbidity and attenuate myeloperoxidase activity and nitric oxide production with minimal impact on viral clearance. This study additionally confirmed nitric oxide, but not hydrogen peroxide, as the major culprit implicated in influenza virus-induced oxido-pathology. Systemic effect of the sustained inflammation and nitrosative stress was more prominent in the spleen and lung than in the liver of mice infected with A/H3N2/Perth/16/09. Influential to immunopathology was heightened pulmonary expression of IL-1β, RANTES, IL-10, MCP-1, NF-κB, iNOS and COX-2. However, kolaviron combated the influenza-established nitrative stress, reversed the elicited cytokine storm and restored the oxidized environment to a reductive milieu. Our data also suggest that kolaviron administration early in infection may foster CD4
<sup>+</sup>
response. These data indicate that kolaviron may confer disease-dwindling properties during acute influenza infection via a system-wide protective approach involving multiple targets especially at the early stage of the infection.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Nigeria</li>
</country>
<region>
<li>État d'Oyo</li>
</region>
<settlement>
<li>Ibadan</li>
</settlement>
<orgName>
<li>Université d'Ibadan</li>
</orgName>
</list>
<tree>
<country name="Nigeria">
<region name="État d'Oyo">
<name sortKey="Awogbindin, Ifeoluwa O" sort="Awogbindin, Ifeoluwa O" uniqKey="Awogbindin I" first="Ifeoluwa O" last="Awogbindin">Ifeoluwa O. Awogbindin</name>
</region>
<name sortKey="Farombi, Ebenezer O" sort="Farombi, Ebenezer O" uniqKey="Farombi E" first="Ebenezer O" last="Farombi">Ebenezer O. Farombi</name>
<name sortKey="Olaleye, David O" sort="Olaleye, David O" uniqKey="Olaleye D" first="David O" last="Olaleye">David O. Olaleye</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A84 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A84 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28116826
   |texte=   Mechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28116826" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021